| Literature DB >> 31871717 |
Kjersti Grønning1,2, Siriwan Lim3, Ola Bratås1.
Abstract
Aim: The aim of this study was to investigate changes in patients' self-management and health status five years after nurse-led patient education. Design: A longitudinal study.Entities:
Keywords: chronic inflammatory arthritis; health status; nurse‐led care; patient education; self‐efficacy; self‐management
Mesh:
Year: 2019 PMID: 31871717 PMCID: PMC6917950 DOI: 10.1002/nop2.394
Source DB: PubMed Journal: Nurs Open ISSN: 2054-1058
Participant characteristic at baseline (N = 101)
|
| % | Mean |
| |
|---|---|---|---|---|
| Men | 29 | 28.7 | ||
| Females | 72 | 71.3 | ||
| Co‐habiting | 86 | 85.1 | ||
| Age | 58.7 | 9.9 | ||
| Education (university level or more) | 34 | 33.7 | ||
| RA | 63 | 62.4 | ||
| PsA | 20 | 19.8 | ||
| UA | 15 | 14.9 | ||
| Disease duration | 11.5 | 9.3 | ||
| Comorbidities | 56 | 55.4 | ||
| Using DMARDs | 82 | 83 | ||
| DAS28−3 | 3.1 | 1.0 |
Abbreviations: DAS28‐3, disease activity score; DMARDS, disease‐modifying anti‐rheumatic drugs; PsA, psoriatic arthritis; RA, rheumatoid arthritis; UA, unspecified polyarthritis.
Changes in health status, disease symptoms and self‐management (n = 101)
| T1 | T2 | Within changes |
| |
|---|---|---|---|---|
| Mean ( | Mean difference (95% CI) | |||
| AIOS (0–100) ↑ | 55.3 (22.4) | 53.7 (18.2) | −1.62 (−7.05 to 3.8) | .554 |
| SE symptoms (10–100) ↑ | 67.9 (16.9) | 68.8 (16.8) | 0.82 (−2.41 to 4.06) | .615 |
| SE pain (10–100) ↑ | 59.2 (19.6) | 61.7 (19.5) | 2.49 (−1.22 to 6.20) | .186 |
| PAM 13 (0–100) ↑ | 66.1 (16.9) | 69.8 (14.5) | 3.69 (0.50 to 6.88) | .024 |
| MHAQ (0–3) ↓ | 1.5 (0.4) | 1.6 (0.6) | 0.12 (0.01 to 0.24) | .035 |
| HADS total (0–42) ↓ | 9.4 (6.5) | 9.8 (7.3) | 0.40 (−0.62 to 1.41) | .442 |
| VAS pain (0–100) ↓ | 42.6 (23.6) | 44.7 (22.9) | 2.04 (−3.55 to 7.63) | .471 |
| VAS tiredness (0–100) ↓ | 49.1 (26.1) | 47.8 (24.1) | −1.29 (−6.77 to 4.19) | .642 |
| VAS disease activity (0–100) ↓ | 43.0 (26.2) | 44.7 (22.5) | 1.69 (−4.55 to 7.93) | .592 |
T1, Last follow‐up in the RCT, T2, 5 years later. Paired T tests, Level of significance.
Abbreviations: ↑, higher score is better; ↓, lower score is better; AIOS, Arizona Integrative Outcomes Scale; HADS, Hospital Anxiety and Depression Scale; MHAQ, modified health assessment questionnaire; PAM13, patient activation measure‐13; SE pain, self‐efficacy pain; SE symptoms, self‐efficacy other symptoms; VAS, 100 mm visual analogue scales.
.
Explained variance in self‐efficacy at five‐year follow‐up
| Co‐ variates | Self‐efficacy other symptoms | Self‐efficacy pain | ||||||
|---|---|---|---|---|---|---|---|---|
| B | Std. Error | Beta |
| B | Std. Error | Beta |
| |
|
| 38.826 | 14.647 | .010 | 48.716 | 19.901 | .016 | ||
| Female | 7.074 | 2.798 | 0.194 | .013 | 12.589 | 3.801 | 0.298 | .001 |
| University education | 2.326 | 2.701 | 0.065 | .392 | 3.944 | 3.670 | 0.096 | .286 |
| Age | 0.052 | 0.133 | 0.031 | .696 | −0.258 | 0.181 | −0.131 | .158 |
| AIOS (0–100) ↑ | 0.052 | 0.084 | 0.056 | .540 | 0.011 | 0.114 | 0.011 | .921 |
| PAM 13 (0–100) ↑ | 0.446 | 0.107 | 0.380 | <.001 | 0.468 | 0.146 | 0.344 | .002 |
| MHAQ (0–3) ↓ | 1.224 | 2.253 | 0.047 | .588 | 0.704 | 3.061 | 0.023 | .819 |
| HADS total (0–42) ↓ | −0.710 | 0.219 | −0.307 | .002 | 0.086 | 0.298 | 0.032 | .774 |
| VAS pain (0–100) ↓ | 0.124 | 0.092 | 0.170 | .184 | −0.035 | 0.126 | −0.041 | .783 |
| VAS tiredness (0–100) ↓ | −0.146 | 0.057 | −0.211 | .012 | −0.155 | 0.077 | −0.193 | .048 |
| VAS disease activity (0–100) ↓ | −0.131 | 0.096 | −0.178 | .175 | −0.172 | 0.130 | −0.201 | .190 |
| Adjusted R2 | 52.6 | 35.0 | ||||||
B = Multiple linear regression analyses, unstandardized coefficients, Std. Error = standard error, Beta = standardized coefficients.
Abbreviations: ↑, higher score is better; ↓, lower score is better; AIOS, Arizona Integrative Outcomes Scale; HADS, Hospital Anxiety and Depression Scale; MHAQ, modified health assessment questionnaire; PAM13, patient activation measure‐13; VAS, 100 mm visual analogue scales.
p‐value < .05.